Certified Advisory Corp’s Nektar Therapeutics NKTR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-49
| Closed | -$15K | – | 542 |
|
|
2021
Q1 | $15K | Buy |
+49
| New | +$15K | ﹤0.01% | 545 |
|
|
2020
Q2 | $29K | Hold |
82
| – | – | 0.01% | 384 |
|
|
2020
Q1 | $22K | Buy |
82
+35
| +74% | +$9.39K | 0.01% | 396 |
|
|
2019
Q4 | $15K | Hold |
47
| – | – | ﹤0.01% | 531 |
|
|
2019
Q3 | $13K | Sell |
47
-75
| -61% | -$20.7K | ﹤0.01% | 551 |
|
|
2019
Q2 | $65K | Sell |
122
-3
| -2% | -$1.6K | 0.02% | 280 |
|
|
2019
Q1 | $63K | Sell |
125
-78
| -38% | -$39.3K | 0.03% | 271 |
|
|
2018
Q4 | $100K | Sell |
203
-3
| -1% | -$1.48K | 0.05% | 197 |
|
|
2018
Q3 | $189K | Buy |
206
+6
| +3% | +$5.51K | 0.09% | 156 |
|
|
2018
Q2 | $146K | Buy |
200
+8
| +4% | +$5.84K | 0.08% | 159 |
|
|
2018
Q1 | $306K | Buy |
192
+26
| +16% | +$41.4K | 0.18% | 113 |
|
|
2017
Q4 | $148K | Buy |
+166
| New | +$148K | 0.11% | 135 |
|